These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 37521234)

  • 61. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
    Singh AK; Devi KN; Bist JS
    Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative Study in Efficacy and Safety of Intralesional Injections of Vitamin D3, Measles Rubella (MR) Vaccine, and Purified Protein Derivative (PPD) in the Management of Cutaneous Warts.
    Ahmed R; Bhadbhade SP; Noojibail B; Shetty SM; Varghese A
    J Cutan Aesthet Surg; 2020; 13(4):326-332. PubMed ID: 33911414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness of intralesional vitamin D
    Kareem IMA; Ibrahim IM; Mohammed SFF; Ahmed AA
    Dermatol Ther; 2019 May; 32(3):e12882. PubMed ID: 30920098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Randomized double Blind Controlled Study Comparing the Efficacy of Intralesional MMR Vaccine with Normal Saline in the Treatment of Cutaneous Warts.
    Agrawal C; Vyas K; Mittal A; Khare AK; Gupta LK
    Indian Dermatol Online J; 2018; 9(6):389-393. PubMed ID: 30505777
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of multiple extragenital warts on quality of life in immune-competent Egyptian adults: a comparative cross-sectional study.
    Salah E
    Clin Cosmet Investig Dermatol; 2018; 11():289-295. PubMed ID: 29928139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolving role of immunotherapy in the treatment of refractory warts.
    Thappa DM; Chiramel MJ
    Indian Dermatol Online J; 2016; 7(5):364-370. PubMed ID: 27730031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
    Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
    Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014.
    Sterling JC; Gibbs S; Haque Hussain SS; Mohd Mustapa MF; Handfield-Jones SE
    Br J Dermatol; 2014 Oct; 171(4):696-712. PubMed ID: 25273231
    [No Abstract]   [Full Text] [Related]  

  • 71. Intralesional antigen immunotherapy for the treatment of warts: current concepts and future prospects.
    Nofal A; Salah E; Nofal E; Yosef A
    Am J Clin Dermatol; 2013 Aug; 14(4):253-60. PubMed ID: 23813361
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Topical treatments for cutaneous warts.
    Kwok CS; Gibbs S; Bennett C; Holland R; Abbott R
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001781. PubMed ID: 22972052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine.
    Nofal A; Nofal E
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1166-70. PubMed ID: 20202055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoimplantation therapy for multiple warts.
    Shivakumar V; Okade R; Rajkumar V
    Indian J Dermatol Venereol Leprol; 2009; 75(6):593-5. PubMed ID: 19915240
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The viral etiology of AIDS-associated malignancies.
    Angeletti PC; Zhang L; Wood C
    Adv Pharmacol; 2008; 56():509-57. PubMed ID: 18086422
    [No Abstract]   [Full Text] [Related]  

  • 76. A Study of Comparison and Evaluation of Various Intralesional Therapies in Cutaneous Warts.
    Chaudhary M; Brar A; Agarwal P; Chavda V; Jagati A; Rathod SP
    Indian Dermatol Online J; 2023; 14(4):487-492. PubMed ID: 37521234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic Review of Intralesional Therapies for Cutaneous Warts.
    Mullen SA; Myers EL; Brenner RL; Nguyen KT; Harper TA; Welsh D; Keffer S; Mueller J; Whitley MJ
    JID Innov; 2024 May; 4(3):100264. PubMed ID: 38585192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intralesional immunotherapy for the treatment of warts: A network meta-analysis.
    Salman S; Ahmed MS; Ibrahim AM; Mattar OM; El-Shirbiny H; Sarsik S; Afifi AM; Anis RM; Yakoub Agha NA; Abushouk AI
    J Am Acad Dermatol; 2019 Apr; 80(4):922-930.e4. PubMed ID: 30003983
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.